Harbor Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Harbor Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,752	Closed	-$1.02M	–	770
2024 Q1	$1.02M	Buy	1,752 +397	+29%	+$223K	0.13%	210
2023 Q4	$719K	Buy	1,355 +114	+9%	+$55.2K	0.14%	190
2023 Q3	$628K	Buy	1,241 +187	+18%	+$99.6K	0.13%	187
2023 Q2	$550K	Buy	1,054 +77	+8%	+$41.6K	0.11%	225
2023 Q1	$563K	Sell	977 -95	-9%	-$53.5K	0.16%	129
2022 Q4	$590K	Sell	1,072 -23	-2%	-$12.2K	0.57%	58
2022 Q3	$555K	Sell	1,095 -374	-25%	-$209K	0.51%	63
2022 Q2	$798K	Sell	1,469 -38	-3%	-$20.9K	0.61%	51
2022 Q1	$890K	Buy	+1,507	New	+$866K	0.42%	65

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbor Capital Advisors's TMO Position: Q2 2024 in Review

Harbor Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 1,752 shares — an estimated $1.02M sold.

Harbor Capital Advisors first reported a position in TMO in Q1 2022 and held it in 9 quarters. The position peaked at $1.02M in Q1 2024. 2,548 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

Harbor Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
Harbor Capital Advisors sold 1,752 Thermo Fisher Scientific shares in Q2 2024, an estimated $1.02M.
Harbor Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 9 quarters.
Harbor Capital Advisors's Thermo Fisher Scientific position peaked at $1.02M in Q1 2024.
2,548 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Harbor Capital Advisors's 13F filing for Q2 2024, filed 9 Jul 2024.